OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Alana Aragón‐Herrera, Manuel Otero-Santiago, Laura Anido‐Varela, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Alana Aragón‐Herrera, Manuel Otero-Santiago, Laura Anido‐Varela, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Showing 6 citing articles:
SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study
Min Xu, Jie Zheng, Tianzhichao Hou, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2718-2728
Open Access | Times Cited: 57
Min Xu, Jie Zheng, Tianzhichao Hou, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2718-2728
Open Access | Times Cited: 57
The role of hepatic microenvironment in hepatic fibrosis development
Ying Meng, Tong Zhao, Zhengyi Zhang, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 2829-2843
Open Access | Times Cited: 18
Ying Meng, Tong Zhao, Zhengyi Zhang, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 2829-2843
Open Access | Times Cited: 18
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Alana Aragón‐Herrera, Sandra Moraña‐Fernández, Manuel Otero-Santiago, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114535-114535
Open Access | Times Cited: 10
Alana Aragón‐Herrera, Sandra Moraña‐Fernández, Manuel Otero-Santiago, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114535-114535
Open Access | Times Cited: 10
A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity
Saiful Iqbal Norazman, Anis Syauqina Mohd Zaffarin, Ahmad Nazrun Shuid, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9399-9399
Open Access | Times Cited: 2
Saiful Iqbal Norazman, Anis Syauqina Mohd Zaffarin, Ahmad Nazrun Shuid, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9399-9399
Open Access | Times Cited: 2
Emerging roles of Sodium-glucose cotransporter 2 inhibitors in Diabetic kidney disease
Tian Gan, Yi Song, Feng Guo, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10915-10924
Closed Access | Times Cited: 4
Tian Gan, Yi Song, Feng Guo, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10915-10924
Closed Access | Times Cited: 4
EFFECT OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS ON LIPID LEVELS IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS
Birsen Doğanay, Özlem Özcan Çelebi
Eskisehir Medical Journal Eskisehir City Hospital (2023)
Open Access | Times Cited: 1
Birsen Doğanay, Özlem Özcan Çelebi
Eskisehir Medical Journal Eskisehir City Hospital (2023)
Open Access | Times Cited: 1
